And Japan? [BE/BA News]

posted by ElMaestro  – Denmark, 2019-12-04 15:43 (1468 d 02:04 ago) – Posting: # 20923
Views: 5,221

Wow,

❝ A: The guideline focuses on BCS-based biowaiver principles to be applied for bioequivalence purposes provided they are supported by a sound scientific rationale. The provision in the guideline that accommodates exceptions to existing regulations that do not permit BCS-based biowaivers for generic product applications, at this time, does not disqualify implementation of these harmonized technical requirements to demonstrate BCS based biowaivers for other product applications unless explicitly stated.


I tried to read that answer 10 times now and I am none the wiser. Do they mean "The guideline will deal with BCS-based biowaivers, but it is acknowledged that some countries might not accept those." ??
:-)

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,824 posts in 4,786 threads, 1,633 registered users;
30 visitors (0 registered, 30 guests [including 5 identified bots]).
Forum time: 17:48 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5